United Services Automobile Association Buys Shares of 8,212 Intuitive Surgical, Inc. $ISRG

Key Points

• United Services Automobile Association invested approximately $4.04 million in Intuitive Surgical, Inc. by acquiring 8,212 shares during the first quarter.
• Intuitive Surgical saw earnings per share of $2.19, surpassing analysts' expectations, with revenue increasing by 21.4% compared to the previous year.
• Several analysts have updated their price targets for Intuitive Surgical, with the average target now at $595.95, reflecting continued bullish sentiment on the stock.

United Services Automobile Association acquired a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 8,212 shares of the medical equipment provider's stock, valued at approximately $4,039,000.

A number of other institutional investors have also modified their holdings of the business. Arete Wealth Advisors LLC increased its holdings in shares of Intuitive Surgical by 14.8% in the 1st quarter. Arete Wealth Advisors LLC now owns 2,191 shares of the medical equipment provider's stock valued at $1,086,000 after acquiring an additional 283 shares during the period. Strait & Sound Wealth Management LLC increased its holdings in shares of Intuitive Surgical by 6.8% in the 1st quarter. Strait & Sound Wealth Management LLC now owns 957 shares of the medical equipment provider's stock valued at $474,000 after acquiring an additional 61 shares during the period. Caxton Associates LLP acquired a new position in shares of Intuitive Surgical in the 1st quarter valued at $780,000. Signature Estate & Investment Advisors LLC increased its holdings in shares of Intuitive Surgical by 17.2% in the 1st quarter. Signature Estate & Investment Advisors LLC now owns 771 shares of the medical equipment provider's stock valued at $382,000 after acquiring an additional 113 shares during the period. Finally, Voleon Capital Management LP increased its holdings in shares of Intuitive Surgical by 61.7% in the 1st quarter. Voleon Capital Management LP now owns 16,635 shares of the medical equipment provider's stock valued at $8,239,000 after acquiring an additional 6,350 shares during the period. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Stock Down 1.4%

Shares of ISRG traded down $6.17 during trading hours on Friday, reaching $449.68. 2,217,474 shares of the company traded hands, compared to its average volume of 2,025,305. The stock has a fifty day simple moving average of $487.55 and a 200 day simple moving average of $509.57. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00. The stock has a market capitalization of $161.20 billion, a PE ratio of 62.72, a price-to-earnings-growth ratio of 4.72 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The company had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.35 billion. During the same period in the prior year, the firm posted $1.78 earnings per share. The firm's revenue was up 21.4% on a year-over-year basis. Research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Activity at Intuitive Surgical

In related news, insider Gary S. Guthart sold 29,360 shares of the business's stock in a transaction dated Friday, August 29th. The stock was sold at an average price of $472.49, for a total value of $13,872,306.40. Following the completion of the sale, the insider directly owned 19,827 shares of the company's stock, valued at $9,368,059.23. The trade was a 59.69% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Amy L. Ladd sold 335 shares of the business's stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $440.69, for a total value of $147,631.15. Following the completion of the sale, the director directly owned 739 shares of the company's stock, valued at approximately $325,669.91. This represents a 31.19% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 45,224 shares of company stock valued at $21,716,492 over the last three months. 0.70% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on the stock. Wall Street Zen upgraded shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Saturday, July 26th. Citigroup reiterated a "buy" rating and issued a $650.00 price objective (up from $590.00) on shares of Intuitive Surgical in a research report on Thursday, May 22nd. BTIG Research lifted their price objective on shares of Intuitive Surgical from $566.00 to $571.00 and gave the company a "buy" rating in a research report on Wednesday, July 23rd. Evercore ISI lifted their price objective on shares of Intuitive Surgical from $470.00 to $550.00 and gave the company an "in-line" rating in a research report on Tuesday, July 8th. Finally, Zacks Research downgraded Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a report on Wednesday, August 20th. Thirteen investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $595.95.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.